Comprehensive overview of biomarkers to predict response to immune checkpoint therapy in lung cancer
Immune checkpoint (IC) therapy has brought a huge revolution in the field of lung cancer treatment over the past decade. It has also revolutionised treatment paradigm and has tremendously improved patient prognosis. IC inhibitors (ICIs) targeting Programmed Cell Death Protein 1/Programmed cell death...
Main Authors: | Kriti Jain, Deepa Mehra, Nirmal Kumar Ganguly, Rashmi Rana, Surajit Ganguly, Shyam Aggarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Current Medicine Research and Practice |
Subjects: | |
Online Access: | http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2023;volume=13;issue=5;spage=232;epage=242;aulast=Jain |
Similar Items
-
PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
by: Tianrui Yang, et al.
Published: (2021-02-01) -
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
by: Pasquale Persico, et al.
Published: (2021-03-01) -
Immune Checkpoint Inhibitors in Cancer Therapy
by: Yavar Shiravand, et al.
Published: (2022-04-01) -
The Role of Immune Checkpoint Inhibitors in Cancer Therapy
by: Ahmed M. Basudan
Published: (2022-12-01) -
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
by: Ruiting Li, et al.
Published: (2021-06-01)